Status:
COMPLETED
Cognitive Remediation in ADHD Children : Comparison Between Three Therapeutic Strategies : Cognitive Remediation With a Virtual Classroom Software and Methylphenidate and Supportive Psychotherapy
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Fondation Caisse d'Epargne
Conditions:
ADHD
Eligibility:
All Genders
7-11 years
Phase:
NA
Brief Summary
The Attention Deficit Disorder with or without Hyperactivity (ADHD) is one of the most frequently found disorder in children. It is characterized by a triad of symptoms involving attention deficit, hy...
Detailed Description
Virtual reality offers the possibility to develop environments approaching situations of daily life that can be used to target evaluation but also for therapeutic purposes. As the school classroom is ...
Eligibility Criteria
Inclusion
- Patient, male or female, aged 7 to 11 years,
- Responding to current diagnostic criteria for ADHD according to DSM IV-TR (Diagnostic and Statistical Manual of Mental Disorders),
- Presenting a total score on the ADHD-RS (ADHD Rating Scale)\> 28 (before treatment),
- Schooled in conventional class,
- Presenting a WISC (Wechsler Intelligence Scale for Children) IV total score\> 80 (done before or in follow-up),
- Registered to social security,
- Legal represent has given informed consent to participate in the study.
Exclusion
- Uncorrected perceptual disorder,
- Patient treated by psychostimulant,
- Patient under supportive psychotherapy,
- Patient treated by methylphenidate,
- Subjects with a pervasive developmental disorder, psychotic disorder, characterized major depressive disorder,
- Subjects who participated in research in the last 3 months,
- Subjects suffering from: glaucoma, hyperthyroidism, thyrotoxicosis, heart diseases (high blood pressure, congestive heart failure, etc…), cerebrovascular disorders,
- Subjects with no deficit in the virtual classroom: having a total number of hit superior to 80 and a number of commissions inferior to 21.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 27 2016
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01821170
Start Date
April 1 2013
End Date
April 27 2016
Last Update
January 27 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux
Bordeaux, France, 33000
2
Centre Hospitalier Charles Perrens
Bordeaux, France, 33076